How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/acute-monocytic-monoblastic-leukemia.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Acute monocytic/monoblastic leukemia — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Acute monocytic/monoblastic leukemia (disease) competitive landscape: 2 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

2 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Acute monocytic/monoblastic leukemia, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	Line of therapy	First approval
Daunorubicin Hydrochloride	daunorubicin	Meiji Seika Pharma Co., Ltd	Anthracycline Topoisomerase Inhibitor	Histone deacetylase 6		1979-01-01
Daunorubicine	Daunorubicine	Gruppo Italiano Malattie EMatologiche dell'Adulto		Multidrug resistance-associated protein 6, 72 kDa type IV collagenase, ATP-binding cassette sub-family G member 2

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

Gruppo Italiano Malattie EMatologiche dell'Adulto · 1 drug in Acute monocytic/monoblastic leukemia
Meiji Seika Pharma Co., Ltd · 1 drug in Acute monocytic/monoblastic leukemia

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Acute monocytic/monoblastic leukemia:

Cite this brief

Drug Landscape (2026). Acute monocytic/monoblastic leukemia — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/acute-monocytic-monoblastic-leukemia. Accessed 2026-06-10.

Acute monocytic/monoblastic leukemia full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing